Serum reagent kit - FLC - Sebia - clinical / laboratory / blood sample
Detection of oligoclonal IgG kappa and IgG lambda bands in cerebrospinal fluid and serum with Hevylite™ antibodies. comparison with the free light chain oligoclonal pattern | Fluids and Barriers of the CNS
Criteria for Presumptive Diagnosis of IgD Multiple Myeloma
November 18, 2022 Sebia, Inc. Karen Anderson Director of Regulatory 1705 Corporate Drive, Suite 400 Norcross, Georgia 30093 Re:
A universal reference interval for serum immunoglobulins free light chains may be outdated
A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay
Evaluation of the new Sebia free light chain assay using the AP22 ELITE instrument - ScienceDirect
Serum reagent kit - FLC - Sebia - clinical / laboratory / blood sample
IJMS | Free Full-Text | Analytical Criticalities Associated to Different Immunological Methods for Serum Free Light Chain Detection in Plasma Cell Dyscrasias: A Description of Particular Clinical Cases
FLC Why choose the Sebia Free Light Chain (FLC) assay?
Next generation free light chain assay - Clinical Laboratory int.
SEBIA FLC - serum free light chain quantification
Sebia And Abingdon Health Sign Exclusive Global Distribution Agreement | Medical Product Outsourcing
Reference ranges of the Sebia free light chain ratio in patients with chronic kidney disease
Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma | Blood Cancer Journal
FLC Why choose the Sebia Free Light Chain (FLC) assay?
A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay
Discrepancy in serum free light chain analysis compared with serum... | Download Scientific Diagram
Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry | Journal of Proteome Research
Evaluation of the new Sebia free light chain assay using the AP22 ELITE instrument - ScienceDirect
Comparison of the distribution of kappa and lambda free light chains... | Download Scientific Diagram
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Table 3 from Prevalence and clinical significance of abnormal serum kappa/ lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
